TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2008: $10.76M2009: $4.95M2010: $4.73M2011: $1.29M2012: $8.35M2013: $4.01M2014: $8.96M2015: $12.95M2016: $64.56M2017: $104.21M2018: $126.89M2019: $140.16M2020: $70.36M2021: $76.37M2022: $72.06M2023: $62.21M2024: $34.28M2025: $58.70M$58.70M
2008Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$58.70M+71.2%
2024$34.28M-44.9%
2023$62.21M-13.7%
2022$72.06M-5.6%
2021$76.37M+8.5%
2020$70.36M-49.8%
2019$140.16M+10.5%
2018$126.89M+21.8%
2017$104.21M+61.4%
2016$64.56M+398.5%
2015$12.95M+44.5%
2014$8.96M+123.7%
2013$4.01M-52.0%
2012$8.35M+546.6%
2011$1.29M-72.7%
2010$4.73M-4.4%
2009$4.95M-54.0%
2008$10.76M—